AbbVie Partners With Argenx In Cancer Deal Spree

AbbVie Inc. is boosting its early-stage oncology pipeline with multiple preclinical licensing deals, including a deal with the Belgian firm argenx, which was followed by a deal with CytomX Therapeutics Inc.